Fig. 4.
Scatter plots for probabilistic sensitivity analysis showing cost effectiveness of ranibizumab compared with a vPDT and b observation. QALY quality-adjusted life-year, vPDT verteporfin photodynamic therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.